1004527-74-5

Basic information

• Product Name: tert-butyl 4-(hydrazinecarbonyl)-4-methylpiperidine-1-carboxylate
• Synonyms: tert-butyl 4-(hydrazinecarbonyl)-4-methylpiperidine-1-carboxylate;tert-butyl 4-(hydrazinecarbonyl)-4-methylpiperidine-1-carboxylate(WXC03710)
• CAS NO: 1004527-74-5
• Molecular Formula: C12H23N3O3
• Molecular Weight: 257.32932
• Mol File: 1004527-74-5.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-butyl 4-(hydrazinecarbonyl)-4-methylpiperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(hydrazinecarbonyl)-4-methylpiperidine-1-carboxylate(1004527-74-5)
• EPA Substance Registry System: tert-butyl 4-(hydrazinecarbonyl)-4-methylpiperidine-1-carboxylate(1004527-74-5)

Safety Data

• Hazardous Substances Data: 1004527-74-5(Hazardous Substances Data)

Upstream product

• 124443-68-1 1-tert-Butyl 4-methyl piperidine-1,4-dicarboxylate 
• 724790-59-4 4-methyl-piperidine-1,4-dicarboxylic acid 1-tert-butyl ester 4-methyl ester 

Relevant articles and documents

NOVEL COMPOUNDS

This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, X, R1, R2, R3 have meanings given in the description.

AMIDE COMPOUNDS

The present invention provides compounds represented by the formula (Ie) and the formula (If) wherein each symbol is as defined in the specification. According to the present invention, these compounds have a DGAT inhibitory activity and are useful for the prophylaxis, treatment or improvement of diseases or pathologies caused by high expression or high activation of DGAT